GlassScriptPhysician profile
John Froude
NPI 1952549321
$333.09
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.19 · 2020: $51.32 · 2021: $17.00 · 2022: $70.87 · 2023: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $70.87 | 2023 | Krystexxa |
| Viiv Healthcare Company | $49.85 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.10 | 2019-2020 | |
| Glaxosmithkline, LLC. | $34.01 | 2022 | |
| Janssen Biotech, INC. | $30.71 | 2019 | |
| Endo Pharmaceuticals INC. | $27.57 | 2020-2023 | Xiaflex |
| Allergan, INC. | $26.32 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.71 | 2019 | |
| Theratechnologies INC. | $13.70 | 2023 | Trogarzo, Egrifta |
| Pfizer INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Froude listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.